Comments on "Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study"
Arthritis Rheumatol. 2025 Jan 19.
doi: 10.1002/art.43117.
Online ahead of print.
1 Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences; Tongji Shanxi Hospital, Taiyuan, China.
2 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
3 Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
4 Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.